The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland : results from the LIPIDOGRAM2015 study
Copyright © 2021 Elsevier B.V. All rights reserved..
BACKGROUND AND AIM: To estimate the prevalence of cardiovascular (CV) disease and CV risk factors among Polish patients.
METHODS: A nationwide cross-sectional study, LIPIDOGRAM2015, was carried out in Poland in the 4th quarter of 2015 and 1st and 2nd quarters of 2016; 438 primary care physicians enrolled 13,724 adult patients that sought medical care in primary health care practices.
RESULTS: Nearly 19% of men and approximately 12% of women had cardiovascular disease (CVD). Over 60% of the recruited patients had hypertension (HTN), >80% had dyslipidaemia and <15% of patients were diagnosed with diabetes (DM). All of these disorders were more frequent in men. In 80% of patients the waist circumference exceed norm for the European population. Less than half of the patients were current smokers or had smoked in the past. Patients with CVD had significantly higher blood pressure and glucose levels but lower low density lipoprotein-cholesterol level.
CONCLUSIONS: The prevalence of CVD and CV risk factors among patients in Poland is high. CVD is more common in men than in women. The most common CV risk factors are excess waist circumference, dyslipidaemia and HTN. Family physicians should conduct activities to prevent, diagnose early and treat CVD in the primary health care population.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Atherosclerosis. Supplements - 42(2020) vom: 29. Dez., Seite e15-e24 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jóźwiak, Jacek J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Blood Glucose |
|---|
| Anmerkungen: |
Date Completed 27.10.2021 Date Revised 27.10.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.atherosclerosissup.2021.01.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321486226 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321486226 | ||
| 003 | DE-627 | ||
| 005 | 20231225175916.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.atherosclerosissup.2021.01.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1071.xml |
| 035 | |a (DE-627)NLM321486226 | ||
| 035 | |a (NLM)33589219 | ||
| 035 | |a (PII)S1567-5688(21)00004-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jóźwiak, Jacek J |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland |b results from the LIPIDOGRAM2015 study |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.10.2021 | ||
| 500 | |a Date Revised 27.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier B.V. All rights reserved. | ||
| 520 | |a BACKGROUND AND AIM: To estimate the prevalence of cardiovascular (CV) disease and CV risk factors among Polish patients | ||
| 520 | |a METHODS: A nationwide cross-sectional study, LIPIDOGRAM2015, was carried out in Poland in the 4th quarter of 2015 and 1st and 2nd quarters of 2016; 438 primary care physicians enrolled 13,724 adult patients that sought medical care in primary health care practices | ||
| 520 | |a RESULTS: Nearly 19% of men and approximately 12% of women had cardiovascular disease (CVD). Over 60% of the recruited patients had hypertension (HTN), >80% had dyslipidaemia and <15% of patients were diagnosed with diabetes (DM). All of these disorders were more frequent in men. In 80% of patients the waist circumference exceed norm for the European population. Less than half of the patients were current smokers or had smoked in the past. Patients with CVD had significantly higher blood pressure and glucose levels but lower low density lipoprotein-cholesterol level | ||
| 520 | |a CONCLUSIONS: The prevalence of CVD and CV risk factors among patients in Poland is high. CVD is more common in men than in women. The most common CV risk factors are excess waist circumference, dyslipidaemia and HTN. Family physicians should conduct activities to prevent, diagnose early and treat CVD in the primary health care population | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cardiovascular disease | |
| 650 | 4 | |a Cardiovascular risk factors | |
| 650 | 4 | |a Diabetes mellitus | |
| 650 | 4 | |a Hypercholesterolaemia | |
| 650 | 4 | |a Hypertension | |
| 650 | 4 | |a Obesity | |
| 650 | 4 | |a Poland | |
| 650 | 4 | |a Primary health care | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 650 | 7 | |a Cholesterol, LDL |2 NLM | |
| 700 | 1 | |a Studziński, Krzysztof |e verfasserin |4 aut | |
| 700 | 1 | |a Tomasik, Tomasz |e verfasserin |4 aut | |
| 700 | 1 | |a Windak, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Mastej, Mirosław |e verfasserin |4 aut | |
| 700 | 1 | |a Catapano, Alberico L |e verfasserin |4 aut | |
| 700 | 1 | |a Ray, Kausik K |e verfasserin |4 aut | |
| 700 | 1 | |a Mikhailidis, Dimitri P |e verfasserin |4 aut | |
| 700 | 1 | |a Toth, Peter P |e verfasserin |4 aut | |
| 700 | 1 | |a Howard, George |e verfasserin |4 aut | |
| 700 | 1 | |a Lip, Gregory Y H |e verfasserin |4 aut | |
| 700 | 1 | |a Tomaszewski, Maciej |e verfasserin |4 aut | |
| 700 | 1 | |a Charchar, Fadi J |e verfasserin |4 aut | |
| 700 | 1 | |a Sattar, Naveed |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Bryan |e verfasserin |4 aut | |
| 700 | 1 | |a MacDonald, Thomas M |e verfasserin |4 aut | |
| 700 | 1 | |a Nowak, Dariusz |e verfasserin |4 aut | |
| 700 | 1 | |a Skowron, Łukasz |e verfasserin |4 aut | |
| 700 | 1 | |a Kasperczyk, Sławomir |e verfasserin |4 aut | |
| 700 | 1 | |a Banach, Maciej |e verfasserin |4 aut | |
| 700 | 0 | |a LIPIDOGRAM2015 Investigators |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Atherosclerosis. Supplements |d 2000 |g 42(2020) vom: 29. Dez., Seite e15-e24 |w (DE-627)NLM111950872 |x 1878-5050 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2020 |g day:29 |g month:12 |g pages:e15-e24 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.atherosclerosissup.2021.01.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2020 |b 29 |c 12 |h e15-e24 | ||